Coronavirus

North Rhine-Westphalia’s State Premier Armin Laschet visits future Bayer AG vaccine production site

Bayer to manufacture mRNA vaccine in Germany

CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

Companies enter into a collaboration and services agreement / Bayer to support CureVac in numerous areas, including development and supply of CVnCoV / CureVac benefits from Bayer´s expertise and established infrastructure / Plan to facilitate the supply of several hundred million doses

Bayer sells a facility at its Wuppertal site to WuXi Biologics

Companies to also enter into long-term sublease agreement and service contract / Buyer planning to use facility to produce COVID-19 vaccine and other biologics

Bayer supports “The Challenge Initiative” of Johns Hopkins Bloomberg School of Public Health with 10 million USD

“The Challenge Initiative” to scale up reproductive health for women and girls in urban poverty areas / Participating cities in East Africa, Francophone West Africa, Nigeria, and India / Integrate COVID-19 prevention and education

Bayer to Provide Crop Relief to Two Million Smallholder Farmers Impacted by COVID-19

Through its new “Better Farms, Better Lives” initiative, Bayer will complement its current commitment to support smallholder farmers in key countries by donating seeds and crop protection inputs / The donations help boost food security by supporting up to two million smallholder farmers facing increased challenges as a result of the on-going COVID-19 pandemic

Bayer to support Harvard Research Study to Evaluate Trust in Science, Including in COVID-19 pandemic

Bayer to donate one million tablets of chloroquine for use in Italy

Added by AIFA along with other drugs to the list of medicines for off-label use against COVID-19

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Investigation of combination therapies including Bayer’s chloroquine and interferon beta-1b to foster much needed solutions for patients in fight against coronavirus pandemic / Bayer Canada to make CAD 1.5 million (approximately 1 million euros) financial commitment and to supply products in support of the research / Plans to include more than 60 contributing research locations involving 6.000 patients

Bayer to donate EUR 1 million to support the fight against COVID-19 in Brazil

Support for projects of the Brazilian government, the national health system and UNICEF

Bayer to donate EUR 1 million to support the fight against the coronavirus pandemic in France

Money will help caregivers, patients and their families, and fund research / Bayer is supporting various further initiatives in France

Bayer donates 8 million chloroquine tablets to the German Federal Government

Additional donations of chloroquine sent to governments in numerous other countries / Various clinical and preclinical studies investigate the efficacy and adverse effects in COVID-19 infections / Bayer plans considerable expansion of production capacities in the event that the efficacy of chloroquine is proven for COVID-19

Bayer supports fight against the corona pandemic in Spain with measures totaling approximately 1 million euros

Bayer planning to hold online-only stockholders’ meeting on April 28, 2020

Stockholders able to exercise right to submit questions and cast votes in a timely manner / Online stockholders’ meeting enables proposed dividend of 2.80 euros per share for 2019 to be paid on time and in full / Baumann: “Reliability for our stockholders is very important, especially during the crisis”

Bayer to boost Germany’s COVID-19 analysis capacity by several thousand tests per day

Bayer donates one million euros for hospitals in Lombardy

Chairman of the Board of Management, Baumann: “Our emergency aid is designed to help support hospitals and hospital staff during the crisis.”

Bayer to donate medicines and money with a total value of approximately EUR 1.5 million

CEO Werner Baumann: “We want to help people in the affected regions quickly and effectively”